Reckitt Benckiser wants out of pharma

Share this article:

Reckitt Benckiser is getting out of the pharmaceutical business. Bloomberg reports that the company plans to spin off the unit so the main company can focus solely on consumer health.

RB expects the split to wrap within the next 12 months, but has indicated it was open to selling the business if it could find a taker. Bloomberg notes that the addiction treatment Suboxone is the division's key drug. CEO Shaun Thaxter is expected to continue to run the unit post spin-off.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters